Loading...

RLAY RELAY THERAPEUTICS INC Product Launches 8-K Filing

RLY

RLY

RELAY THERAPEUTICS INC

(RLAY)

2023 8-K

Financial Statements

Lease Amendments

Financial Results

Conference Announcement

Clinical Data Update

Financial Results

Clinical Data Release

Financial Results Announcement

Termination of Agreement

Collaboration and New Programs

Financial Results Announcement

Financial Results Announcement

Private Placement

Financial Results Announcement

Clinical Data Announcement

Earnings Reports

Financial Results Announcement

Financial Results Announcement

Investor Conferences

External Links:

Relay Therapeutics, Inc. announced the initial clinical data for RLY-2608, an investigational cancer inhibitor, presented at the AACR Annual Meeting 2023.

AI Assistant

RELAY THERAPEUTICS INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.